These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 15554621)
1. [Gd-AAZTA]-: a new structural entry for an improved generation of MRI contrast agents. Aime S; Calabi L; Cavallotti C; Gianolio E; Giovenzana GB; Losi P; Maiocchi A; Palmisano G; Sisti M Inorg Chem; 2004 Nov; 43(24):7588-90. PubMed ID: 15554621 [TBL] [Abstract][Full Text] [Related]
2. Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes. Doble DM; Melchior M; O'Sullivan B; Siering C; Xu J; Pierre VC; Raymond KN Inorg Chem; 2003 Aug; 42(16):4930-7. PubMed ID: 12895117 [TBL] [Abstract][Full Text] [Related]
3. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. Hermann P; Kotek J; Kubícek V; Lukes I Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444 [TBL] [Abstract][Full Text] [Related]
4. Orthogonal synthesis of a heterodimeric ligand for the development of the Gd(III)-Ga(III) ditopic complex as a potential pH-sensitive MRI/PET probe. Vologdin N; Rolla GA; Botta M; Tei L Org Biomol Chem; 2013 Feb; 11(10):1683-90. PubMed ID: 23360969 [TBL] [Abstract][Full Text] [Related]
5. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands. Pierre VC; Melchior M; Doble DM; Raymond KN Inorg Chem; 2004 Dec; 43(26):8520-5. PubMed ID: 15606201 [TBL] [Abstract][Full Text] [Related]
6. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity. Xu J; Churchill DG; Botta M; Raymond KN Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797 [TBL] [Abstract][Full Text] [Related]
7. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents. Ferreira MF; Martins AF; Martins JA; Ferreira PM; Tóth E; Geraldes CF Chem Commun (Camb); 2009 Nov; (42):6475-7. PubMed ID: 19841814 [TBL] [Abstract][Full Text] [Related]
8. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
10. A highly stable gadolinium complex with a fast, associative mechanism of water exchange. Thompson MK; Botta M; Nicolle G; Helm L; Aime S; Merbach AE; Raymond KN J Am Chem Soc; 2003 Nov; 125(47):14274-5. PubMed ID: 14624565 [TBL] [Abstract][Full Text] [Related]
11. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates. Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates. Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of High Relaxivity Gadolinium AAZTA Tetramers as Building Blocks for Bioconjugation. Tripepi M; Capuana F; Gianolio E; Kock FVC; Pagoto A; Stefania R; Digilio G; Aime S Bioconjug Chem; 2018 Apr; 29(4):1428-1437. PubMed ID: 29470084 [TBL] [Abstract][Full Text] [Related]
14. Cyclen-based Gd Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196 [TBL] [Abstract][Full Text] [Related]
15. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling. Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118 [TBL] [Abstract][Full Text] [Related]
16. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon. Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679 [TBL] [Abstract][Full Text] [Related]
17. Coordination chemistry of amide-functionalised tetraazamacrocycles: structural, relaxometric and cytotoxicity studies. Martinelli J; Balali-Mood B; Panizzo R; Lythgoe MF; White AJ; Ferretti P; Steinke JH; Vilar R Dalton Trans; 2010 Nov; 39(42):10056-67. PubMed ID: 20877892 [TBL] [Abstract][Full Text] [Related]
18. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents. Gugliotta G; Botta M; Tei L Org Biomol Chem; 2010 Oct; 8(20):4569-74. PubMed ID: 20740241 [TBL] [Abstract][Full Text] [Related]
19. Impact of rigidification on relaxometric properties of a tricyclic tetraazatriacetic gadolinium chelate. Port M; Raynal I; Vander Elst L; Muller RN; Dioury F; Ferroud C; Guy A Contrast Media Mol Imaging; 2006; 1(3):121-7. PubMed ID: 17193688 [TBL] [Abstract][Full Text] [Related]
20. A gadolinium(III) complex of a carboxylic-phosphorus acid derivative of diethylenetriamine covalently bound to inulin, a potential macromolecular MRI contrast agent. Lebdusková P; Kotek J; Hermann P; Vander Elst L; Muller RN; Lukes I; Peters JA Bioconjug Chem; 2004; 15(4):881-9. PubMed ID: 15264877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]